in ,

BioNTech Shares Plummet After Whistleblower Report On Fake Data, Faulty Trials

Reports of a Pfizer pill for COVID treatment could also be a contributing factor

Reuters / Dado Ruvic


Shares of the German biotechnology company BioNTech that co-developed a Covid-19 vaccine with America’s Pfizer took a dramatic 20-percent plunge on Friday, in wake of a damning whistleblower report.

The price of BioNTech shares traded on the US NASDAQ exchange briefly fell by some $60 and stood at around $216 at the time of writing.


Some analysts have immediately tied the dramatic fall – which amounted to more than 20% – to the publication of an explosive report on the trial of the Pfizer-BioNTech Covid jab. Published in the British Medical Journal (BMJ) on Tuesday, the report cites a former contractor and claims to expose a staggering level of incompetence in management, handling of data and patient safety during the testing process.

Read More

Leave a Reply


Democrats Laughing At American’s Complaints About High Gas Prices

Pfizer ‘Claims’ It’s New COVID-19 Pill Cuts Hospitalization, Death Risks By 90%